Profil
Michael Culler is the founder of Tiburio Therapeutics, Inc. He is currently the Director & Chief Scientific Officer at Amolyt Pharma SAS, a position held since 2018.
Aktiva positioner av Michael Culler
| Företag | Position | Start |
|---|---|---|
Amolyt Pharma SAS
Amolyt Pharma SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development in physical & natural sciences | Teknisk/Vetenskaplig/F&U Direktör | 2018-03-01 |
Tidigare kända positioner av Michael Culler
| Företag | Position | Slut |
|---|---|---|
Tiburio Therapeutics, Inc.
Tiburio Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnological research and developmental services | Grundare | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 2 |
|---|---|
Amolyt Pharma SAS
Amolyt Pharma SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development in physical & natural sciences | Commercial Services |
Tiburio Therapeutics, Inc.
Tiburio Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnological research and developmental services | Health Technology |
















